Susan D Aster

USPTO Granted Patents = 11 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 58(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 1996-2012

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8178546 - Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 (2012-05-15),

2. 8026264 - Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1 (2011-09-27),

3. 7504402 - Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1 (2009-03-17),

4. 7329683 - 11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia (2008-02-12),

5. 6849636 - Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 (2005-02-01),

6. 6048869 - Tricyclic compounds (2000-04-11),

7. 5886005 - 4-Aza-19-norandrostane derivatives (1999-03-23),

8. 5760045 - Delta-17 and delta-20 olefinic and saturated (1998-06-02),

9. 5741795 - 16-substituted-6-aza-androsten-4-ene-3-ones as 5-.alpha.-reductase (1998-04-21),

10. 5510485 - 17-ester, amide, and ketone derivatives of 3-oxo-4-azasteroids as (1996-04-23),

11. 5510351 - Delta-17 and delta-20 olefinic and saturated 17 beta-substituted 4-aza-5 (1996-04-23),

Title: The Innovative Contributions of Susan D Aster

Introduction

Susan D Aster is a prominent inventor based in Teaneck, NJ (US), known for her significant contributions to the field of medicinal chemistry. With a total of 11 patents to her name, she has made remarkable advancements in the development of compounds that target various metabolic disorders.

Latest Patents

Among her latest patents are the innovative compounds known as Diaryltriazoles, which serve as inhibitors of the 11-beta-hydroxysteroid dehydrogenase-1 enzyme. These compounds are particularly useful in treating conditions such as diabetes, hyperglycemia, obesity, insulin resistance, atherosclerosis, dyslipidemia, hyperlipidemia, hypertension, and Metabolic Syndrome. Additionally, she has developed triazole derivatives that also act as selective inhibitors of the same enzyme, further contributing to the treatment of noninsulin-dependent diabetes and related symptoms.

Career Highlights

Throughout her career, Susan has worked with notable companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her work has been instrumental in advancing therapeutic options for patients suffering from metabolic disorders.

Collaborations

Susan has collaborated with esteemed colleagues, including Donald W Graham and James M Balkovec, to enhance her research and development efforts.

Conclusion

Susan D Aster's innovative work in the field of medicinal chemistry has led to significant advancements in the treatment of metabolic disorders. Her contributions continue to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.